Description

Synjardy is a prescription medication that combines two active ingredients, empagliflozin and metformin, used to improve blood sugar control in adults with type 2 diabetes. It works by helping the kidneys remove glucose from the bloodstream and improving insulin sensitivity.

Interpreter Notes

Interpreters should be aware that patients may refer to Synjardy by its components, empagliflozin and metformin, which are common in discussions about diabetes management. It is important to maintain a formal register and avoid colloquial terms when interpreting. Some patients might confuse Synjardy with similar diabetes medications, so clarity is crucial.

Example Sentences

EN: The doctor prescribed Synjardy to help manage my diabetes more effectively.

ES: El médico me recetó Synjardy para ayudar a manejar mi diabetes de manera más efectiva.

Common Interpreter Mistakes

Confusing Synjardy with other diabetes medications; mispronouncing 'empagliflozin' as 'empagliflozina'; using informal language when discussing medication.